| Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 2.73M | 2.69M | 2.60M | 2.31M | 2.31M | 2.44M |
| Gross Profit | 1.32M | 2.58M | 2.46M | 2.22M | 2.18M | 2.18M |
| EBITDA | 1.87M | 2.65M | 1.82M | 1.58M | 7.58M | 1.59M |
| Net Income | 1.56M | 1.57M | 1.36M | 1.14M | 5.42M | 3.65M |
Balance Sheet | ||||||
| Total Assets | 46.75M | 44.99M | 44.73M | 43.07M | 42.77M | 36.35M |
| Cash, Cash Equivalents and Short-Term Investments | 609.00K | 1.73M | 397.00K | 3.27M | 3.49M | 2.00M |
| Total Debt | 11.38M | 9.98M | 10.84M | 9.95M | 9.94M | 10.00M |
| Total Liabilities | 15.13M | 13.50M | 14.10M | 13.14M | 13.22M | 11.64M |
| Stockholders Equity | 31.62M | 31.49M | 30.63M | 29.94M | 29.55M | 24.71M |
Cash Flow | ||||||
| Free Cash Flow | 917.00K | 1.64M | 1.23M | 563.00K | 1.10M | 561.00K |
| Operating Cash Flow | 1.54M | 1.64M | 1.23M | 563.00K | 1.10M | 561.00K |
| Investing Cash Flow | -3.03M | 1.78M | -4.29M | 27.00K | 1.03M | 3.07M |
| Financing Cash Flow | 664.00K | -2.08M | -239.00K | -786.00K | -645.00K | -2.92M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | £22.27M | 11.12 | 24.60% | 7.10% | 7.02% | -12.85% | |
73 Outperform | £23.87M | 9.02 | 5.00% | 3.16% | -0.91% | 7.43% | |
70 Outperform | £24.39M | 5.00 | 5.05% | ― | -7.14% | ― | |
69 Neutral | £27.29M | 19.57 | 4.45% | 0.91% | -2.80% | 30.05% | |
66 Neutral | £42.47M | 54.66 | 4.34% | 7.14% | -41.22% | ― | |
65 Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% | |
46 Neutral | £17.59M | -0.19 | -34.93% | ― | 196.14% | 12.75% |